Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Last Week’s Dow Losers: International Business Machines Corp. (IBM), Exxon Mobil Corporation (XOM)

While last week’s biggest loser, Merck & Co., Inc. (NYSE:MRK) managed to perform slightly better this week and lose the least-coveted title, it did still end the week lower than were it began. Shares dropped 0.48% after the company lost a lawsuit and was ordered to pay $285,000 to the plaintiff, as a federal court found that Merck had failed to warn doctors that a drug called Fosamax had possible side effects. While this penalty is small when compared with Merck’s overall position, there are more than 4,000 similar pending lawsuits that could pose a real threat to the company’s overall health.

Finally, we come to this week’s biggest Dow loser: Pfizer Inc. (NYSE:PFE) , whose shares fell 2.71% over the past five trading days. Last week, Pfizer was flirting with its 52-week high, but as investor fears of a correction grow stronger, companies trading close to their yearly highs are likely to experience a selloff as investors lock in their gains. This past week was actually relatively quiet for the company, other than the announcement that the FDA chose a competitor’s drug for an Alzheimer’s study. The big drug manufacturers will probably find themselves fighting uphill battles for the next few years as a number of blockbuster drugs fall off patent and the generic manufacturers begin eating market share.

More Foolish insight
Are you at ease, or nervous? It’s been a great five-year run for investors, with the Dow and S&P at or near all-time highs. Yet fears abound. When will the next downturn hit? Will political gridlock lead to portfolio-killing inflation? To learn how to protect your portfolio, click here for free guidance from the Motley Fool Pro Academy!

The article Last Week’s Dow Losers originally appeared on Fool.com and is written by Matt Thalman.

Fool contributor Matt Thalman has no position in any stocks mentioned. Follow Matt on Twitter: @mthalman5513. The Motley Fool owns shares of IBM. Try any of our Foolish newsletter services free for 30 days. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.